CohBar (CWBR) and Morphogenesis, Inc. Enter into Definitive Merger Agreement May 23, 2023 07:32AM
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth May 23, 2023 07:30AM
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth May 23, 2023 07:30AM
CohBar (CWBR) retained Ladenburg Thalmann & Co. Inc. as a financial advisor to assist the Company in exploring strategic alternatives Nov 17, 2022 08:48AM